Showing results (1761-1770 of 2,088) with videos related to

Sort By:
Pageof 209
Cancer Cell|July 5, 2008
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibitionIrina Nickeleit, Steffen Zender, Florenz Sasse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group StudyEric Raymond, Alba A Brandes, Christian Dittrich, et al.
Circulation|April 2, 2003
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidaseRalf Dechend, Christiane Viedt, Dominik N Müller, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2013
New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951Thierry Gorlia, Jean-Yves Delattre, Alba A Brandes, et al.
Redox Biology|December 2, 2017
The NADPH organizers NoxO1 and p47phox are both mediators of diabetes-induced vascular dysfunction in miceFlávia Rezende, Franziska Moll, Maria Walter, et al.
American Heart Journal|November 4, 2020
Atrial fibrillation is a marker of increased mortality risk in nonischemic heart failure-Results from the DANISH trialRune Boas, Jens Jakob Thune, Steen Pehrson, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 1, 2020
Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trialRune Boas, Jens Jakob Thune, Steen Pehrson, et al.
Hemasphere|July 20, 2023
Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood ETV6::RUNX1+ and High Hyperdiploid Acute Lymphoblastic LeukemiaDanielle Brandes, Layal Yasin, Karin Nebral, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial)Giuseppe Lombardi, Paola Del Bianco, Alba A Brandes, et al.
Free Radical Biology & Medicine|November 20, 2016
Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assaysFlávia Rezende, Kim-Kristin Prior, Oliver Löwe, et al.
Pageof 209